Skip to main content

Sobi Q1 Report 2014

Document   •   May 08, 2014 09:04 GMT

Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the first quarter 2014. Revenues totalled SEK 573.3 M (528.5), an increase of 8 per cent. The Partner Products portfolio was a highlight, with 70 per cent growth compared to the first quarter last year.
License Creative Commons Attribution (?)